Faculty Information - Junpei Sanada

（Last updated : 2024-10-24 10:04:03）

Junpei Sanada
Department Kawasaki Medical School Kawasaki Medical School, Department of Diabetes, Endocrinology and Metabolism,

Position Instructor

■ Present specialized field

Metabolism and endocrinology, Metabolism and endocrinology

■ Journal

1.	2024/08	Nilotinib-induced Diabetes in Japanese Patients with Chronic Myeloid Leukemia
2.	2024/07	C-peptide index at 2 hour after meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes
3.	2024/07	Effectiveness of switching from dipeptidyl peptidase-4 inhibitor to oral glucagon-like peptide-1 receptor agonist in Japanese participants with type 2 diabetes mellitus: Prospective observational study using propensity score matching
4.	2024/07	The impact of handgrip strength and waist circumference on glycemic control: Prospective, observational study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus
5.	2024/06	Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice
6.	2024/06	The Impact of Hand Strength on HbA1c, Body Mass Index and Body Composition by Group According to Sedentary Behaviour: Cross-Sectional Study in Japanese Patients with Type 2 Diabetes Mellitus
7.	2024/05/23	Clinical findings of acute necrotizing esophagitis complicated by diabetic ketoacidosis
8.	2024/04	The impact of grip strength, waist circumference, and body mass index on Hemoglobin A(1c) value: Cross-sectional study using outpatient clinical data in Japanese elderly patients with type 2 diabetes mellitus
9.	2024/03/19	Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ
10.	2024/01/04	Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study
11.	2023/09/20	Structural and functional differences in auto-antibody positive compared to auto-antibody negative hypothyroid patients with chronic thyroiditis
12.	2023/08/17	Simple standing test without furosemide is useful in the diagnosis of primary aldosteronism
13.	2023/07/31	Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjects
14.	2023/07	Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study
15.	2023/03/15	Influence of Nutritional Guidance/Consulting on Glycemic Control during the Coronavirus Disease 2019 Pandemic in Patients with Type 2 Diabetes Mellitus
16.	2023/01/30	A Male Subject with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Which Was Diagnosed at 31 Years Old due to Infertility
17.	2023/01/23	Incidence of endocrine-related immune-related adverse events in Japanese subjects with various types of cancer
18.	2022/10/27	Correlation of Baba's diabetic neuropathy classification with various diabetes-related complications
19.	2022/10/21	Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of cushing's syndrome: comparison of CAR with findings in dexamethasone suppression test
20.	2022/10/13	Association between changes in pancreatic morphology and vascular complications in subjects with type 2 diabetes mellitus: a retrospective study
21.	2022/08/02	Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules
22.	2022/05/12	Effect of hyperglycemia-related acute metabolic disturbance on thyroid function parameters in adults.
23.	2022/04	Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
24.	2022/03	Molecular Mechanism of Pancreatic β-Cell Failure in Type 2 Diabetes Mellitus
25.	2021/10	Amelioration of hypercalcemia by cinacalcet treatment in a subject with relapsing acquired hypocalciuric hypercalcemia: A case report
26.	2021/10	Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency
27.	2015	A case of disseminated pyomyositis in poorly controlled type 2 diabetes with diabetic ketoacidosis.
Display 5 items
Display all(27)

■ Presentation

1.	2024/09/11	Elucidation of a new mechanism of action of GLP-1 focusing on pancreatic islet blood flow - Investigation by in vivo imaging - （Speech，General）
2.	2023/06/24	DPP-4 inhibitor and SGLT2 inhibitor additively ameliorate hepatic steatosis in NAFLD model mice through different action mechanisms （Poster notice，General）
3.	2023/06/24	GLP-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes ～Randomized, parallel-group, multicenter, open-label trial～（Poster notice，General）
4.	2023/06/24	Protective effects of DPP-4 inhibitor and SGLT2 inhibitor on pancreatic β-cell function: Randomized, parallel-group, multicenter, open-label study (SECRETE-I) （Poster notice，General）